openPR Logo
Press release

What's driving the Cancer supportive care products Market Trends? Amgen, Johnson & Johnson, Novartis Ag, Baxter International, Fagron Group BV, Hoffmann LA- Roche Inc, Acacia Pharma Ltd

What's driving the Cancer supportive care products Market

The strong prevalence of cancer and the chronicity of the disease is the primary driver of the global cancer supportive care products market. There will be nearly 24 million cancer patients across the world by 2035 according to a recent report by the WCRF and most of them will need care for quite a number of years as cancer does not cause sudden death in most cases. A number of healthcare organizations have recognized the escalating demand from cancer patients and are opening specialized care centers as well as investing in the research and development of products that serve them adequately.

Some of the other factors augmenting demand in the global cancer supportive care products market are: increasing geriatric population who are more prone to the disease, greater effectiveness of anti-cancer treatments, rising prevalence of several forms of cancer, high demand for improved cancer supportive care therapies, increasing focus on maintaining superior quality of life, and availability in alternative dosage forms in compounding pharmacies.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/5336

On the other hand, loss of brand exclusivity of various generic drugs, entry of biosimilars, rising costs of innovation holding R&D investments, and regulatory barriers are some of the key factors restraining the cancer supportive care products market. Therefore, lack of blockbuster drugs would mean that in the next five years, the market would be defined in part by development of new formulas, combinations, and delivery devices.

Competitive Landscape
• Amgen Inc.
• Johnson & Johnson Private Ltd.
• Novartis AG
• Baxter International Inc
• Hoffmann-La Roche Ltd.
• Fagron Group BV
• Teva Pharmaceutical Industries Ltd.

As the PMR report foresees the future of the cancer supportive care products market, the demand will expand at a notable CAGR of 4.8% during the forecast period of 2017 to 2021. In terms of revenue, the concerned market is poised to attain a valuation of US$ 31,700.0 Mn by the end of 2021, considerably more than its evaluated 2017 worth of US$ 26,285.5 Mn in 2017.

On the basis of drug class, the report segments the market for cancer supportive care products into nonsteroidal erythropoietin stimulating agents, opioid analgesics, anti-imflammatory drugs, anti-infective drugs, bisphosphonates, anti-emetics drugs, monoclonal antibodies, and granulocyte colony stimulating factor. Indication-wise, the market has been bifurcated into lung cancer, prostate cancer, breast cancer, leukemia, ovarian cancer, bladder cancer, liver cancer, melanoma, and others.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/5336

On the other hand, loss of brand exclusivity of various generic drugs, entry of biosimilars, rising costs of innova-tion holding R&D investments, and regulatory barriers are some of the key factors restraining the cancer support-ive care products market. Therefore, lack of blockbuster drugs would mean that in the next five years, the market would be defined in part by development of new formulas, combinations, and delivery devices.

Table of Contents

1. Executive Summary
2. Research Methodology
3. Assumption & Acronyms Used
4. Market Overview
4.1. Parent Market Overview

4.2. Market Taxonomy & Market Definition
4.3. Global Cancer Supportive Care Products Market Size and Forecast
4.3.1. Introduction
4.3.2. Market Value Forecast & Y-o-Y Growth Rate (2015-2021)

4.4. Global Cancer Supportive Care Products Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Trends
4.4.4. Opportunity

5. Regulations & PEST Analysis
6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug Class
6.1.1. Introduction
6.1.2. Y-o-Y Growth Comparison, By Drug Class
6.1.3. BPS Analysis, By Drug Class

6.1.3.1. Nonsteroidal Anti-inflammatory Drugs
6.1.3.2. Anti-infective
6.1.3.3. Anti-emetics
6.1.3.4. Monoclonal Antibodies

6.1.3.5. Erythropoietin Stimulating Agents
6.1.3.6. Opioid Analgesics
6.1.3.7. Bisphosphonates
6.1.3.8. Granulocyte Colony Stimulating Factor
6.1.4. Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class

Buy Now @ https://www.persistencemarketresearch.com/checkout/5336

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Cancer supportive care products Market Trends? Amgen, Johnson & Johnson, Novartis Ag, Baxter International, Fagron Group BV, Hoffmann LA- Roche Inc, Acacia Pharma Ltd here

News-ID: 1762132 • Views: 201

More Releases from persistencemarketresearch.com

Demand for Fruit Pulp to Hit the Sweet Spot Across Markets in Europe and the Mid …
Persistence Market Research has recently published a new report titled “Fruit Pulp Market: Global Industry Analysis 2012–2016 & Forecast 2017–2025,” which is a comprehensive market study pertaining to the demand and supply of different forms of fruit pulp across various end use industries. In this report, Persistence Market Research analyzes the global fruit pulp market value chain and presents insights on the different factors influencing global market revenue growth over
Global Market Study on ePRO, E-Patient Diaries and eCOA: E-Patient Diaries Solut …
Global ePRO, E-Patient Diaries and eCOA Market: Overview Technological advancements in the healthcare sector have resulted in the adoption of new technologies for clinical trials. Some of these technologies include Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient Diaries (E-Patient Diaries). eCOA uses advanced mobile technology such as smartphones, tablets, and personal computers to allow patients, clinicians, and their caregivers to directly report outcomes. eCOA generates highly accurate data that allows
Global Market Study on Vitamin Supplements: Vitamin B Product Segment Projected …
Over the past year, the use of term “virtual reality” with several product categories has increased to a manifold extent. Companies are creating new segmentations in their product lines to reap from the surging adoption of virtual reality technologies. Persistence Market Research’s new report on the global virtual reality market projects that by 2022-end, the global market for VR technologies will be worth over US$ 6 billion. The study offers
Vitamins Supplements Market 2025 : Technology Growing Rapidly Due to High Qualit …
Various dietary or nutritional supplements are provided to people to help them cure their body deficiencies. These supplements include vitamins, provitamins, and nutrients. Vitamin supplements are of various types such as multi vitamin, Vitamin B, Vitamin C, Vitamin D etc. The global market for vitamin supplements is expected to exhibit a robust growth surge with the increase in health awareness among people. Persistence Market Research has come up with its new

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and